CONRIG PHARMA ApS: Financial statements 2014
CVR: 33373236
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
CONRIG PHARMA ApS (CVR 33373236) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK -92,788 and a net result of DKK -81,341 compared with DKK -274,036 the year before. Equity in the 2014 report amounted to DKK 94,066. The solvency ratio was 45.1%.
- Gross Profit
- DKK -92,788
- Profit/Loss
- DKK -81,341
- Equity
- DKK 94,066
- Total Assets
- DKK 208,794
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | -93 t. | -81 t. | 94 t. | - |
| 2013 | - | -228 t. | -274 t. | 276 t. | - |
| 2012 | - | -266 t. | -244 t. | 200 t. | - |
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
CONRIG PHARMA ApS has published its annual report for 2013. Gross profit came to DKK -227,519, and the net result was DKK -274,036.
About CONRIG PHARMA ApS
CONRIG PHARMA ApS is a Danish company of the type Anpartsselskab based in Vedbæk, founded in 2010. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Snickar Karl Johan Tobieson and Lars Christer Fredrik Fåhraeus. The company is owned by Melius Pharma AB. The company has 0 employees (2011). In 2025, the company reported a gross profit of DKK -98,936 and a net result of DKK -95,786 compared with DKK -100,217 the year before. Equity in the 2025 report amounted to DKK 0.